Literature DB >> 30744542

Magnetic Resonance Imaging or Computed Tomography Before Treatment in Acute Ischemic Stroke.

Corentin Provost1, Marc Soudant2, Laurence Legrand1, Wagih Ben Hassen1, Yu Xie3, Sébastien Soize4, Romain Bourcier5, Joseph Benzakoun1, Myriam Edjlali1, Grégoire Boulouis1, Hélène Raoult6, Francis Guillemin2, Olivier Naggara1, Serge Bracard3, Catherine Oppenheim1.   

Abstract

Background and Purpose- The acute management of stroke patients requires a fast and efficient screening imaging modality. We compared workflow and functional outcome in acute ischemic stroke patients screened by magnetic resonance imaging (MRI) or computed tomography (CT) before treatment in the THRACE trial (Thrombectomie des Artères Cérébrales), with the emphasis on the duration of the imaging step. Methods- The THRACE randomized trial (June 2010 to February 2015) evaluated the efficacy of mechanical thrombectomy after intravenous tPA (tissue-type plasminogen activator) in ischemic stroke patients with proximal occlusion. The choice of screening imaging modality was left to each enrolling center. Differences between MRI and CT groups were assessed using univariable analysis and the impact of imaging modality on favorable 3-month functional outcome (modified Rankin Scale score of ≤2) was tested using multivariable logistic regression. Results- Four hundred one patients were included (25 centers), comprising 299 MRI-selected and 102 CT-selected patients. Median baseline National Institutes of Health Stroke Scale score was 18 in both groups. MRI scan duration (median [interquartile range]) was longer than CT (MRI: 13 minutes [10-16]; CT: 9 minutes [7-12]; P<0.001). Stroke-onset-to-imaging time (MRI: median 114 minutes [interquartile range, 89-138]; CT: 107 minutes [88-139]; P=0.19), onset-to-intravenous tPA time (MRI: 150 minutes [124-179]; CT: 150 minutes [123-180]; P=0.38) and onset-to-angiography-suite time (MRI: 200 minutes [170-250]; CT: 213 minutes [180-246]; P=0.57) did not differ between groups. Imaging modality was not significantly associated with functional outcome in the multivariable analysis. Conclusions- Although MRI scan duration is slightly longer than CT, MRI-based selection for acute ischemic stroke patients is accomplished within a timeframe similar to CT-based selection, without delaying treatment or impacting functional outcome. This should help to promote wider use of MRI, which has inherent imaging advantages over CT. Clinical Trial Registration- URL: https://www.clinicaltrials.gov . Unique identifier: NCT01062698.

Entities:  

Keywords:  brain ischemia; magnetic resonance imaging; thrombectomy; treatment outcome; workflow

Mesh:

Year:  2019        PMID: 30744542     DOI: 10.1161/STROKEAHA.118.023882

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  23 in total

Review 1.  Clinical Imaging of the Penumbra in Ischemic Stroke: From the Concept to the Era of Mechanical Thrombectomy.

Authors:  Lucie Chalet; Timothé Boutelier; Thomas Christen; Dorian Raguenes; Justine Debatisse; Omer Faruk Eker; Guillaume Becker; Norbert Nighoghossian; Tae-Hee Cho; Emmanuelle Canet-Soulas; Laura Mechtouff
Journal:  Front Cardiovasc Med       Date:  2022-03-09

Review 2.  Imaging selection for reperfusion therapy in acute ischemic stroke beyond the conventional time window.

Authors:  Lauranne Scheldeman; Anke Wouters; Robin Lemmens
Journal:  J Neurol       Date:  2021-10-31       Impact factor: 4.849

3.  Retinal and optic nerve magnetic resonance diffusion-weighted imaging in acute non-arteritic central retinal artery occlusion.

Authors:  Matthew Boyko; Oana Dumitrascu; Amit M Saindane; Joseph M Hoxworth; Ranliang Hu; Tanya Rath; Wesley Chan; Alexis M Flowers; Ehab Harahsheh; Parth Parikh; Omer Elshaigi; Benjamin I Meyer; Nancy J Newman; Valérie Biousse
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-07-15       Impact factor: 2.677

4.  CT- versus MRI-Based Imaging for Thrombolysis and Mechanical Thrombectomy in Ischemic Stroke: Analysis from the Austrian Stroke Registry.

Authors:  Stefan Krebs; Alexandra Posekany; Alina Pilz; Julia Ferrari; Alexandra Bernegger; Christian Neumann; Siegfried Thurnher; Dominik Roth; Wilfried Lang; Marek Sykora
Journal:  J Stroke       Date:  2022-09-30       Impact factor: 8.632

5.  Synthetic MRI for stroke: a qualitative and quantitative pilot study.

Authors:  Joachim André; Sami Barrit; Patrice Jissendi
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

6.  Clot Burden Score and Collateral Status and Their Impact on Functional Outcome in Acute Ischemic Stroke.

Authors:  I Derraz; M Pou; J Labreuche; L Legrand; S Soize; M Tisserand; C Rosso; M Piotin; G Boulouis; C Oppenheim; O Naggara; S Bracard; F Clarençon; B Lapergue; R Bourcier
Journal:  AJNR Am J Neuroradiol       Date:  2020-11-12       Impact factor: 3.825

7.  Age and discharge modified Rankin score are associated with 90-Day functional outcome after basilar artery occlusion treated with endovascular therapy.

Authors:  Rahul R Karamchandani; Dale Strong; Jeremy B Rhoten; Tanushree Prasad; Jacob Selig; Gary Defilipp; Andrew W Asimos
Journal:  Interv Neuroradiol       Date:  2021-01-07       Impact factor: 1.764

Review 8.  MR Imaging in Neurocritical Care.

Authors:  Anurima Patra; Amit Janu; Arpita Sahu
Journal:  Indian J Crit Care Med       Date:  2019-06

9.  In vivo photoacoustic imaging dynamically monitors the structural and functional changes of ischemic stroke at a very early stage.

Authors:  Jing Lv; Shi Li; Jinde Zhang; Fei Duan; Zhiyou Wu; Ronghe Chen; Maomao Chen; Shanshan Huang; Haosong Ma; Liming Nie
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

10.  Association of initial imaging modality and futile recanalization after thrombectomy.

Authors:  Thomas Raphael Meinel; Johannes Kaesmacher; Pascal John Mosimann; David Seiffge; Simon Jung; Pasquale Mordasini; Marcel Arnold; Martina Goeldlin; Steven D Hajdu; Marta Olivé-Gadea; Christian Maegerlein; Vincent Costalat; Laurent Pierot; Joanna D Schaafsma; Urs Fischer; Jan Gralla
Journal:  Neurology       Date:  2020-08-26       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.